In January 2023, the world was abuzz with stories of a revolutionary weight-loss drug – a simple, self-administered injection ...

PGC-1α research offers new hope for weight loss by boosting metabolic efficiency and providing accessible management ...

Eli Lilly's popular obesity drug Zepbound can now be covered by government-backed Medicare drug plans, CNBC reported on ...

Polls provide a useful window into understanding how Americans view their own weight and the recent availability of drugs ...

In a recent episode of the global health and wellness show Bloom, host Gayle Guyardo welcomed Dr. Bharti Shetye, MD, MFOMA, a ...

Novo Nordisk faces scrutiny over UK pharmacy sponsorships tied to weight-loss drugs, with critics citing conflicts of interest and regulatory breaches.

To accomplish these goals, it's fair to assume that some people will ultimately turn to weight-loss drugs such as Ozempic and ...

If the drug is currently prescribed for another purpose, DSS said it would no longer cover the cost after Jan. 15. Now, Medicaid enrollees who use GLP-1 agonists for weight loss won’t have many ...

Wegovy was approved by the FDA in 2021, after showing it helped ... ‘Novo Nordisk is going to have a new drug [where] 40% of people will get 25% weight loss, but that’ll be pretty ...

“Among adults, 5.4% of all prescriptions in September 2024 were for GLP-1s,” Rodriguez says. That is up from 3.5% a year earlier, in 2023, and 1% at the start of 2021.

18 (UPI) --Merck announced a weight loss drug deal Wednesday ... an experimental oral GLP-1 drug made by China-based Eccogene. France confirms first case of new mpox strain Jan. 7 (UPI) -- French ...

The food and beverage giant is once again addressing the growing popularity of weight-loss drugs with a protein shot designed ... A randomised study involving 26 people with type-2 diabetes in 2021 ...